SCHEMBL23155124

SCHEMBL23155124

c1ccc(N(c2ccc(-c3ccc4c(c3)-c3c5cccc3-c3cccc-4c3-c3ccccc3-5)cc2)c2ccc3oc4ccccc4c3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ PLA2G2A P14555 4/20 0.34
▸ PLA2G4A P47712 4/20 0.34
▸ ALOX5 P09917 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ LMNA P02545 3/20 0.33
▸ L3MBTL1 Q9Y468 3/20 0.33
▸ AHR P35869 1/20 0.33
▸ APAF1 O14727 1/20 0.33
▸ THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23155311 0.98 PLA2G2A (0.37) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL23155330 0.94 NPC1 (0.36) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL23155122 0.93 MMP12 (0.35) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL23155370 0.93 MAPT (0.39) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL23155313 0.91 MEN1 (0.36) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL23155317 0.90 PLA2G2A (0.34) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL16684057 0.88 NPC1 (0.39) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL23155354 0.87 MEN1 (0.37) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL25580698 0.86 NPC1 (0.38) NPC1MAPTMEN1RAB9AKMT2A
SCHEMBL25580623 0.86 NPC1 (0.38) NPC1MAPTMEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-28 — — US disclosed
EP-3799144-B1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-06-01 — — EP disclosed
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11594684-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, SMCHD1, CXCR1 NPC1 2344/4885MAPT 4116/4885MEN1 1466/4885
US-20210098700-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, SMCHD1, CXCR1 NPC1 2344/4885MAPT 4116/4885MEN1 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback